Literature DB >> 12395089

Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.

Albert C Lo1, Joel A Black, Stephen G Waxman.   

Abstract

Voltage-gated sodium channels contribute to the development of axonal degeneration in white matter, and sodium channel blocking drugs are known to have a protective effect on acutely injured white matter axons. To determine whether phenytoin has a protective effect on axons in a neuroinflammatory model, we studied the effect of phenytoin on axonal degeneration in the optic nerve in MOG-induced experimental allergic encephalomyelitis (EAE). We report that, whereas approximately 50% of optic nerve axons are lost at 27-28 days in untreated EAE, only approximately 12% of the axons are lost if mice with MOG-induced EAE are treated with phenytoin. These results demonstrate that it is possible to achieve substantial protection of white matter axons in EAE, a model neuroinflammatory/demyelination disease, with a sodium channel blocking agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395089     DOI: 10.1097/00001756-200210280-00015

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.

Authors:  M Inglese; G Madelin; N Oesingmann; J S Babb; W Wu; B Stoeckel; J Herbert; G Johnson
Journal:  Brain       Date:  2010-01-27       Impact factor: 13.501

Review 2.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

Review 3.  Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Authors:  D Caccamo; L R Pisani; P Mazzocchetti; R Ientile; P Calabresi; F Pisani; C Costa
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

Review 4.  Sodium channels in astroglia and microglia.

Authors:  Laura W Pappalardo; Joel A Black; Stephen G Waxman
Journal:  Glia       Date:  2016-02-26       Impact factor: 7.452

Review 5.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers.

Authors:  M P Kurnellas; K C Donahue; S Elkabes
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

7.  Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.

Authors:  Muriel B Sättler; Sarah K Williams; Clemens Neusch; Markus Otto; Jens R Pehlke; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.

Authors:  Heather A O'Malley; Andrew B Shreiner; Gwo-Hsiao Chen; Gary B Huffnagle; Lori L Isom
Journal:  Mol Cell Neurosci       Date:  2008-11-01       Impact factor: 4.314

9.  Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis.

Authors:  Getaw Worku Hassen; Jason Feliberti; Leo Kesner; Alfred Stracher; Foroozan Mokhtarian
Journal:  Brain Res       Date:  2008-08-12       Impact factor: 3.252

Review 10.  Neuroprotection and repair in multiple sclerosis.

Authors:  Robin J M Franklin; Charles ffrench-Constant; Julia M Edgar; Kenneth J Smith
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.